Stay updated on 4D-125 in XLRP Patients Clinical Trial
Sign up to get notified when there's something new on the 4D-125 in XLRP Patients Clinical Trial page.

Latest updates to the 4D-125 in XLRP Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has undergone significant updates regarding the clinical trial for the gene therapy 4D-125 for X-linked Retinitis Pigmentosa, including changes to the trial's structure and participant criteria. Notably, the previous version's detailed descriptions of the study phases and inclusion/exclusion criteria have been removed, while new information about the trial's design and patient enrollment has been added.SummaryDifference35%
- Check67 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 21, 2025.SummaryDifference0.3%
- Check81 days agoChange DetectedThe page has updated the number of study locations from 7 to 8 and added specific details about a location in Salt Lake City, Utah. Additionally, the last update date has been changed to March 2025.SummaryDifference2%
Stay in the know with updates to 4D-125 in XLRP Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 4D-125 in XLRP Patients Clinical Trial page.